CTD-M 6.25/50 Tablet ER

Overview CTD-M 6.25/50 Tablet ER

Amlodipine/Atenolol Extended-Release tablets (6.25mg/50mg) are indicated for managing hypertension (high blood pressure) when monotherapy proves insufficient. This combination therapy helps regulate blood pressure, lessening the risk of future strokes and heart attacks. Early use improves survival rates following a cardiac event. Ideally taken once daily in the morning, with or without food, to minimize nocturnal urination, this medication should be continued as directed by your physician. Discontinuing the medication prematurely, even with symptom improvement, is inadvisable as hypertension often presents asymptomatically. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, further enhance blood pressure control. Closely follow your doctor's instructions. Common side effects include nausea, constipation, diarrhea, and fatigue; consult your doctor if these persist, worsen, or are bothersome. Increased fluid intake can mitigate muscle weakness, dry mouth, and thirst. Initial dizziness or headaches, potentially due to lowered blood pressure, usually subside. Prior to commencing treatment, inform your physician of any liver or kidney conditions, pregnancy, or breastfeeding. Complete disclosure of all current medications, especially those for hypertension or cardiac issues, is essential. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium and magnesium) is necessary to assess therapeutic efficacy.

Primary Ingredients of CTD-M 6.25/50 Tablet ER

No text was provided to rephrase. Please provide the text you wish to have rewritten.

Uses of CTD-M 6.25/50 Tablet ER

Elevated blood pressure

Major Benefits of CTD-M 6.25/50 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-M 6.25/50 Tablet ER whole; do not break, crush, or chew it. While it can be taken with or without food, consistent timing is recommended.

Common Side effects of CTD-M 6.25/50 Tablet ER:

• Nausea
• Constipation
• Diarrhea
• Fatigue
• Headache
• Dizziness
• Slow heart rate
• Increased blood uric acid
• Decreased potassium level in blood
• Glucose intolerance
• Altered blood lipid level
• Cold extremities
• Decreased magnesium level in blood
• Increased calcium level in blood

How to use CTD-M 6.25/50 Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-M 6.25/50 Tablet ER may be consumed with or without food, though consistent timing is recommended.

How CTD-M 6.25/50 Tablet ER works:

Each CTD-M 6.25/50 extended-release tablet contains Metoprolol Succinate and Chlorthalidone, two agents that work together to reduce high blood pressure. Metoprolol Succinate, a beta-blocker, acts directly on the heart, slowing the heartbeat and enhancing its pumping efficiency. Chlorthalidone, a diuretic, lowers blood pressure by eliminating excess fluid and electrolytes, while also promoting vasodilation and improved circulation.

What if you forget to take CTD-M 6.25/50 Tablet ER :

Should you forget a CTD-M 6.25/50 mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.